1 / 38

Immunization and Vaccine Preventable Diseases

Immunization and Vaccine Preventable Diseases . Department of Child Health, Medical School, Padjadjaran University. Learning Objectives. At the end of the presentation , students will be able to: Describe the difference between active and passive immunity

ula
Télécharger la présentation

Immunization and Vaccine Preventable Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immunization and Vaccine Preventable Diseases Department of Child Health, Medical School, Padjadjaran University

  2. Learning Objectives At the end of the presentation , students will be able to: • Describe the difference between active and passive immunity • List some group of vaccine-preventable diseases • List group of live attenuated and inactivated vaccines • For each vaccine-preventable disease, identify those for whom routine immunization is recommended • For each vaccine-preventable disease, describe the characteristics of the vaccine used to prevent the disease

  3. INTRODUCTION • WHO & UNICEF: preventable infectious diseases cause two-thirds of child deaths worldwide • Without vaccines : epidemics of many preventable diseases could return • increased - and unnecessary - illness, disability, and death among children

  4. INTRODUCTION • Immunization saves the lives of approximately 3 million people each year, all over the world • Immunization is among the safest of modern medical interventions • Immunization is one of the most cost-effective health interventions

  5. IMMEDIATE GOAL: PREVENTION OF DISEASE IN INDIVIDUAL OR GROUPS ULTIMATE GOAL: ERADICATION IMMUNIZATION GOAL

  6. PRINCIPELS OF VACCINATION Active Immunity • Protection produced by the person's own immune system • Usually permanent • Protection transferred from another person or animal • Temporary protection that wanes with time Passive Immunity

  7. Vaccination • Active immunity produced by vaccine • Immunity and immunologic memory similar to natural infection but without risk of disease

  8. IMMUN RESPONS Primary Antigen Contanct Secundary Antigen Contact Secundar respons Primer respons

  9. VACCINE-PREVENTABLE DISEASES

  10. VACCINE-PREVENTABLE DISEASES • Most common and serious vaccine-preventable diseases (WHO) : - tuberculosis - diphtheria, pertussis, tetanus - poliomyelitis - measles, mumps, rubella - Haemophilusinfluenzae type b (Hib) - yellow fever • Other common vaccine-preventable diseases : influenza and pneumococcal pneumonia

  11. EXPANDED PROGRAM IMMUNIZATION (EPI) TARGET DISEASES

  12. VACCINE PREVENTABLE DISEASES

  13. EPIDEMIOLOGY Tetanus—United States, 1947-2006 Diphtheria - United States, 1940-2006 Year

  14. Live oral vaccine Last indigenous case Poliomyelitis—United States, 1950-2006 Measles – United States, 1950 - 2006 Inactivated vaccine Vaccine licensed Live oral vaccine

  15. Hepatitis A - United States, 1966-2006 Vaccine Licensed Vaccine Licensed Year

  16. Bacteria Vaccine Virus Vaccine Live attenuated Inactivated CLASSIFICATION OF VACCINE • Measles • Mums • Rubella • Varicella • BCG • OPV • Yellow • Fever • Influenza • Diphtheria • Tetanus • Pertussis • Cholera • Meningo • Pneumo • Hib • Typhim Vi • IPV • Rabies • Hepatitis B • Hepatitis A

  17. THE MAJOR CONSTITUENTS OF VACCINES • Active immunizing antigen - Tetanus or diphtheria toxoid, acellular pertussis component, varicella, etc. • Conjugating agents - Carrier proteins of proven immunologic potential (eg, tetanus toxoid, nontoxic variant of diphtheria toxin) • Suspending fluid - Sterile water, Saline solution, etc • Presevatives, stabilizers, and antimicrobial agents - Thiomersal, Neomycin, Streptomycin sulfate, etc • Adjuvants : - Alumunium salt

  18. Contraindications and Precautions Permanent contraindications to vaccination: • severe allergic reaction to a vaccine component or following a prior dose • encephalopathy not due to another identifiable cause occurring within 7 days of pertussis vaccination (applies only to pertussis-containing vaccines)

  19. Contraindications and Precautions Inactivated C C V* V P V Condition Allergy to component Encephalopathy Pregnancy Immunosuppression Severe illness Recent blood product Live C --- C C P P** C=contraindication P=precaution V=vaccinate if indicated *except HPV and Tdap. **MMR and varicella-containing (except zoster vaccine), and rotavirus vaccines only

  20. Invalid Contraindications to Vaccination • Mild illness • Antimicrobial therapy • Disease exposure or convalescence • Pregnant or immunosuppressed person in the household • Breastfeeding • Preterm birth • Allergy to products not present in vaccine or allergy that is not anaphylactic • Family history of adverse events • Tuberculin skin testing • Multiple vaccines

  21. Screening Questions • Is the child (or are you) sick today? • Does the child have an allergy to any medications, food, or any vaccine? • Has the child had a serious reaction to a vaccine in the past? • Has the child had a seizure, brain or nerve problem? • Has the child had a health problem with asthma, lung disease, heart disease, kidney disease, metabolic disease, such as diabetes, or a blood disorder?

  22. RECCOMENDED IMMUNIZATION SCHEDULE • UNITED STATES 2007 AND 2010 • INDONESIAN MINISTRY OF HEALTH • INDONESIAN PEDIATRICS ASSOCIATION (IPS) = IKATAN DOKTER ANAK INDONESIA (IDAI)

  23. Guidelines for Spacing of Live and Inactivated Antigens

  24. EXPANDED PROGRAM IMMUNIZATION

  25. NON-EXPANDED PROGRAM IMMUNIZATION MMR (Measles, Mumps, Rubella) Prevention: Measles, Mumps and Rubella AAP recommended at 12-15 months of age; Second dose at 4-6 years of age IDAI recommended as booster at 15 month and 6 years of age Dose: 0.5 ml subcutan

  26. 2. Hib (Haemophilus influenzae tipe b) Two conjugate vaccines licensed for use in infants • PRP-T ActHIB, TriHIBit • PRP-OMP PedvaxHIB, Comvax Recommended at 2, 4, and 6 month; booster at 12 – 15 month of age Dose: 0.5 ml, intramuscular

  27. 3. Typhoid Fever There are 2 type - Polisacharida vaccine (injection) - Capsular vi Polisakharida vaccine (oral) Recommended at 2 year of age and the booster every 3 year 4. Hepatitis A - Schedule: > 2 year (2 dose, interval 6 month) - Dose: 720 U

  28. 5. Varicella AAP recommended at 12-15 months of age; Second dose at 4-6 years of age IDAI recommended at 5-12 years of age Dose: 0,5 ml subcutan 6. Pnemococcal (PCV7) Major clinical syndromes include pneumonia, bacteremia, and meningitis Doses at 2, 4, 6, months of age, booster dose at 12-15 months of age. Dose: 0.5 ml intramuscular

  29. 7. Influenza < 8 years of age: 2 dose (interval min 4 week) Dose: 0.25 ml (6-35 months of age) 0.5 ml (> 3years of age) Booster: anually

  30. LAPSED IMMUNIZATIONS • A lapse in the immunization schedule does not require reinstitution of the entire series or addition of doses to the series. UNKNOWN OR UNCERTAIN IMMUNIZATION STATUS □ Many children do not have adequate documentation □ In general, when in doubt: recommended immunization should be initiated without delay on a schedule commensurate with the person’s current age.

  31. THANK YOU

More Related